Search
Intellia Therapeutics Inc
NTLAAdd to Watchlist
12.080USD
+0.420+3.60%
Market hours 11/03, 12:38（ET）
1.69BMarket Cap
LossP/E TTM
Intellia Therapeutics Inc (NTLA) Revenue Performance
Updated: Jun 30, 2026By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
FY2025
FY2024
FY2023
FY2022
United States
67.67M(100.00%)
57.88M(100.00%)
36.27M(100.00%)
52.12M(100.00%)